Results 231 to 240 of about 51,825 (261)

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

Update on Cardiac Myosin Inhibitors and Potential Role in Treating Obstructive Hypertrophic Cardiomyopathy

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2023
Michael J, Litt, Sharlene M, Day
openaire   +2 more sources

Cardiac Myosin Inhibitors

Journal of the American College of Cardiology
Torsten B. Rasmussen, Anne M. Dybro, Morten Kvistholm Jensen   +2 more
openaire   +1 more source

Cardiac myosin inhibitors in the treatment of hypertrophic cardiomyopathy (literature review)

Pharmateca, 2023
L.V. Kononenko Kononenko, G.G. Taradin Taradin, G.A. Ignatenko Ignatenko   +2 more
openaire   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann, Nadine Krüger, Tobias S Schiergens   +2 more
exaly  

The adenosine pathway in immuno-oncology

Nature Reviews Clinical Oncology, 2020
Bertrand Allard, Laurence Buisseret, John Stagg   +2 more
exaly  

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly